Private company
Tabula Rasa HealthCare, Inc.
Tabula Rasa HealthCare, Inc. is an American business services company based in Moorestown, active since 2014.2
Last updated Oct 20, 2026.
Overview
- IndustryServices-Business Services, NEC2
- HeadquartersMoorestown, United States2
- Incorporated inDE3
- Business address228 Strawbridge Drive, Suite 100, Moorestown, Nj 080573
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formCorporation2
- LEI549300K6KY242XRMEF282
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O CAPITOL SERVICES, INC., 19901 Dover, United States2
- Registered withDivision of Corporations, Department of State, 55379732
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue78¢$232.6M
- Research and development5¢$14.5M
- Other costs17¢$52.0M
- Income tax0¢$389.0K
Out of $299.5M in revenue.4 The company lost money this year.
Where each dollar of operating cash went, fiscal 2022
- Capital spending31¢$2.3M
- Kept or used elsewhere69¢$5.1M
Out of $7.4M of cash from operations.4
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | $94.8M5 | $133.5M6 | $204.3M7 | $284.7M8 | $221.4M4 | $259.9M4 | $299.5M4 |
| Cost of revenue | $65.2M5 | $93.7M6 | $137.7M7 | $181.4M8 | $160.6M4 | $193.4M4 | $232.6M4 |
| Gross profit | $28.9M9 | ||||||
| Research and development | $3.8M5 | $5.6M6 | $12.2M7 | $21.7M8 | $14.4M4 | $14.6M4 | $14.5M4 |
| Operating expenses | $109.2M4 | $135.9M4 | |||||
| Operating income | $5.3M5 | $4.1M6 | -$49.7M7 | -$32.6M8 | -$41.2M4 | -$42.7M4 | -$69.0M4 |
| Interest | $4.5M5 | $688.0K6 | $906.0K7 | $16.0M8 | $20.7M8 | $9.1M8 | |
| Income before tax | -$51.8M4 | -$76.9M4 | |||||
| Income tax | $541.0K5 | -$9.3M6 | -$3.4M7 | -$16.2M8 | -$5.4M4 | $390.0K4 | $389.0K4 |
| Net income | -$5.5M5 | $12.8M6 | -$47.3M7 | -$32.4M8 | -$81.0M4 | -$79.1M4 | -$147.5M4 |
| Earnings per share | -$0.415 | $0.766 | -$2.486 | -$1.578 | -$3.714 | -$3.394 | -$6.074 |
| Earnings per share (diluted) | -$0.535 | $0.686 | -$2.486 | -$1.578 | -$3.714 | -$3.394 | -$6.074 |
| Shares (weighted, basic) | 23.3M shares4 | 24.3M shares4 | |||||
| Shares (weighted, diluted) | 23.3M shares4 | 24.3M shares4 |
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash | $4.3M12 | $10.4M5 | $20.3M7 | $42.5M8 | $22.5M4 | $9.4M4 | $70.0M4 |
| Receivables | $21.4M4 | $19.3M4 | |||||
| Inventory | $5.4M4 | $6.6M4 | |||||
| Current assets | $15.7M12 | $35.5M5 | $63.3M6 | $94.5M7 | $93.2M8 | $89.9M4 | $170.3M4 |
| Goodwill | $115.3M4 | $115.3M4 | |||||
| Intangible assets | $45.4M4 | $38.3M4 | |||||
| Total assets | $72.7M12 | $187.8M5 | $271.0M6 | $492.4M7 | $514.4M8 | $499.4M4 | $384.1M4 |
| Accounts payable | $8.9M4 | $19.5M4 | |||||
| Current liabilities | $11.0M12 | $27.8M5 | $75.7M6 | $40.0M7 | $72.2M8 | $73.9M4 | $102.1M4 |
| Long-term debt | $226.3M6 | ||||||
| Total liabilities | $16.6M12 | $63.9M5 | $131.9M6 | $306.8M7 | $345.9M8 | $443.7M4 | $441.2M4 |
| Retained earnings | -$260.3M4 | -$407.9M4 | |||||
| Shareholders’ equity | $59.0M6 | $123.9M7 | $139.0M8 | $185.5M4 | $168.5M4 | $55.8M4 | -$57.0M4 |
| Shares outstanding | 16.6M shares12 | 19.3M shares5 | 20.6M shares6 | 22.3M shares7 | 24.0M shares8 | 25.7M shares4 | 27.1M shares4 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash from operations | $6.8M5 | $18.3M6 | $15.8M7 | -$5.8M8 | $4.8M4 | $15.5M4 | $7.4M4 |
| Depreciation and amortization | $20.5M4 | $23.3M4 | |||||
| Stock-based compensation | $38.5M8 | $32.4M4 | |||||
| Capital spending | $3.8M5 | $3.3M6 | $5.0M7 | $7.5M8 | $3.1M4 | $3.4M4 | $2.3M4 |
| Free cash flow | $3.0M | $15.0M | $10.8M | -$13.3M | $1.7M | $12.1M | $5.1M |
| Cash from investing | -$35.2M4 | $91.3M4 | |||||
| Share buybacks | $959.0K6 | $2.9M7 | |||||
| Cash from financing | $6.9M4 | -$32.0M4 |
Corporate structure
Tabula Rasa HealthCare, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Tabula Rasa HealthCare, Inc.
- Indaba Capital Management, L.P. Filed SC 13D/A on Tabula Rasa HealthCare, Inc., latest Nov 14, 2023 (7 filings since May 20, 2022)
- VANGUARD GROUP INC Filed SC 13G/A on Tabula Rasa HealthCare, Inc., latest Feb 9, 2023 (2 filings since Feb 10, 2022)
- Macquarie Group Filed SC 13G/A on Tabula Rasa HealthCare, Inc., latest Jun 10, 2022 (2 filings since Feb 14, 2022)
- Credit Suisse Filed SC 13G/A on Tabula Rasa HealthCare, Inc., latest Feb 14, 2022
- Artisan Partners Limited Partnership Filed SC 13G/A on Tabula Rasa HealthCare, Inc., latest Feb 4, 2022
- FIRST TRUST PORTFOLIOS LP Filed SC 13G/A on Tabula Rasa HealthCare, Inc., latest Jan 10, 2022
- Tabula Rasa HealthCare, Inc. Moorestown, New Jersey, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Tabula Rasa HealthCare, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Operating-lease assets (leased space) | $10.5M4 Dec 31, 2022 | $16.3M4 Dec 31, 2021 | −35.8% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $70.0M4 Dec 31, 2022 | $9.4M4 Dec 31, 2021 | +645.3% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $115.3M4 Dec 31, 2022 | $115.3M4 Dec 31, 2021 | 0% |
| Intangible assets, net (excluding goodwill) | $38.3M4 Dec 31, 2022 | $45.4M4 Dec 31, 2021 | −15.5% |
| Finite-lived intangibles, gross | $69.0M4 Dec 31, 2022 | $69.0M4 Dec 31, 2021 | 0% |
| Accumulated amortization | $30.7M4 Dec 31, 2022 | $23.7M4 Dec 31, 2021 | +29.7% |
| Finite-lived intangibles, net | $38.3M4 Dec 31, 2022 | $45.4M4 Dec 31, 2021 | −15.5% |
Inventory
Leadership
Who has led Tabula Rasa HealthCare, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerCalvin H. Knowlton Sep 28, 2016 to Aug 3, 202213
- PresidentOrsula Knowlton V. Sep 28, 2016 to Aug 3, 202214
- Chief financial officerThomas Cancro Mar 4, 2022 to Nov 14, 202315
- Chief operating officerMichael Greenhalgh Mar 10, 2020 to Nov 14, 202316
Board members and other officers (16)
- Chief Accounting OfficerAndrea Carolan Speers Mar 2, 2018 to Jan 18, 202217
- Board memberDerek C. Schrier Sep 16, 2022 to Nov 14, 202318
- Board memberRonald Paul Mitchell Oct 12, 2022 to Nov 14, 202319
- Board memberPamela Schweitzer Mar 6, 2019 to Nov 14, 202320
- Board memberJan Berger Jul 19, 2018 to Jun 14, 202221
- Board memberMichael J. Purcell Jul 19, 2018 to Nov 14, 202322
- Board memberKathrine O'Brien Nov 5, 2018 to Nov 14, 202323
- Board memberDennis Helling Mar 13, 2017 to Nov 14, 202324
- Board memberSamira Beckwith Aug 11, 2017 to Nov 14, 202325
- Board memberBruce Luehrs Sep 28, 2016 to Jun 18, 201826
- Board memberCalvin H. Knowlton Sep 28, 2016 to Aug 3, 202213
- Board memberDaniel C. Lubin Sep 28, 2016 to Dec 12, 201727
- Board memberGlen R. Bressner Sep 28, 2016 to Jun 19, 201828
- Board memberGordon Tunstall Sep 28, 2016 to Jun 14, 202229
- Board memberOrsula Knowlton V. Sep 28, 2016 to Aug 3, 202214
- General counselRichard W. Rew Ii. Apr 19, 2023 to Nov 14, 202330
Timeline
- Nov 6, 20238-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale31
- Nov 3, 20238-K Completed an acquisition or sale32
- Oct 31, 20238-K Shareholder vote; Other events33
- Oct 19, 20238-K Other events34
- Aug 7, 20238-K Entered a material agreement; Other events35
- Aug 7, 20238-K Results of operations36
- Aug 4, 20238-K Executive or director change37
- Jun 14, 20238-K Shareholder vote38
- May 17, 20238-K Regulation FD disclosure39
- May 8, 20238-K Results of operations40
- Apr 13, 20238-K Results of operations; Executive or director change; Regulation FD disclosure41
- Mar 6, 20238-K Results of operations42
- Sep 28, 2016New chief executive Calvin H. Knowlton becomes CEO13
- May 21, 2014Founded Tabula Rasa HealthCare, Inc. is founded2
Calendar
When it reported results
- Aug 7, 2023Reported quarterly or annual results36
- May 8, 2023Reported quarterly or annual results40
- Apr 13, 2023Reported quarterly or annual results41
- Mar 6, 2023Reported quarterly or annual results42
- Jan 17, 2023Reported quarterly or annual results43
- Nov 3, 2022Reported quarterly or annual results44
- Aug 4, 2022Reported quarterly or annual results45
- Jul 20, 2022Reported quarterly or annual results46
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
180 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 33 major events, 90 insider forms, 14 large holders, 35 other. The latest 20:
- Nov 16, 2023EFFECT EDGAR
- Nov 16, 2023EFFECT EDGAR
- Nov 16, 2023EFFECT EDGAR
- Nov 16, 2023EFFECT EDGAR
- Nov 16, 2023EFFECT EDGAR
- Nov 16, 2023EFFECT EDGAR
- Nov 16, 2023EFFECT EDGAR
- Nov 16, 2023EFFECT EDGAR
- Nov 16, 2023EFFECT EDGAR
- Nov 14, 20234 EDGAR
- Nov 14, 20234 EDGAR
- Nov 14, 20234 EDGAR
- Nov 14, 20234 EDGAR
- Nov 14, 20234 EDGAR
- Nov 14, 20234 EDGAR
- Nov 14, 20234 EDGAR
- Nov 14, 20234 EDGAR
- Nov 14, 20234 EDGAR
- Nov 14, 20234 EDGAR
- Nov 14, 20234 EDGAR
The 180 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
44 open-market trades by officers, directors and large owners since October 2021: 12 buys and 32 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 12, 2022 | Cancro ThomasCHIEF FINANCIAL OFFICER | Buy | 11,500 | $4.34 | $49.9K | Form 4 |
| Dec 9, 2022 | Purcell Michael J.Director | Sale | 10,000 | $4.26 | $42.6K | Form 4 |
| Jul 25, 2022 | Indaba Capital Management, L.P.Director | Buy | 59,262 | $4.28 | $253.6K | Form 4 |
| Jul 22, 2022 | SCHRIER DEREK CDirector | Buy | 293,292 | $4.23 | $1.2M | Form 4 |
| Jul 21, 2022 | SCHRIER DEREK CDirector | Buy | 1,000,000 | $3.90 | $3.9M | Form 4 |
| Mar 4, 2022 | Helling DennisDirector | Buy | 5,000 | $6.17 | $30.9K | Form 4 |
| Mar 2, 2022 | Purcell Michael J.Director | Buy | 10,000 | $5.84 | $58.4K | Form 4 |
| Mar 1, 2022 | Greenhalgh MichaelCHIEF OPERATING OFFICER | Buy | 2,000 | $5.63 | $11.3K | Form 4 |
| Mar 1, 2022 | TUNSTALL GORDONDirector | Buy | 10,000 | $5.50 | $55.0K | Form 4 |
| Jan 14, 2022 | Greenhalgh MichaelCHIEF OPERATING OFFICER | Sale | 2,010 | $14.87 | $29.9K | Form 4 |
| Jan 14, 2022 | Adams Brian WCHIEF EXECUTIVE OFFICER | Sale | 2,523 | $14.86 | $37.5K | Form 4 |
| Jan 14, 2022 | Speers Andrea CarolanChief Accounting Officer | Sale | 1,280 | $14.87 | $19.0K | Form 4 |
| Jan 12, 2022 | Greenhalgh MichaelCHIEF OPERATING OFFICER | Sale | 1,088 | $15.69 | $17.1K | Form 4 |
| Jan 12, 2022 | Adams Brian WCHIEF EXECUTIVE OFFICER | Sale | 1,958 | $15.68 | $30.7K | Form 4 |
| Jan 12, 2022 | Speers Andrea CarolanChief Accounting Officer | Sale | 1,131 | $15.67 | $17.7K | Form 4 |
| Jan 4, 2022 | Speers Andrea CarolanChief Accounting Officer | Sale | 958 | $15.54 | $14.9K | Form 4 |
| Jan 4, 2022 | Greenhalgh MichaelCHIEF OPERATING OFFICER | Sale | 1,585 | $15.54 | $24.6K | Form 4 |
| Jan 4, 2022 | Adams Brian WCHIEF EXECUTIVE OFFICER | Sale | 2,664 | $15.54 | $41.4K | Form 4 |
| Jan 3, 2022 | Speers Andrea CarolanChief Accounting Officer | Sale | 1,330 | $15.67 | $20.8K | Form 4 |
| Jan 3, 2022 | Greenhalgh MichaelCHIEF OPERATING OFFICER | Sale | 1,100 | $15.67 | $17.2K | Form 4 |
All 44 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Indaba Capital Management, L.P.SC 13D/A, 7 filings May 20, 2022 to Nov 14, 202347
- VANGUARD GROUP INCSC 13G/A, 2 filings Feb 10, 2022 to Feb 9, 202348
- Macquarie GroupSC 13G/A, 2 filings Feb 14, 2022 to Jun 10, 202249
- Credit SuisseSC 13G/A, 1 filing Feb 14, 202250
- Artisan Partners Limited PartnershipSC 13G/A, 1 filing Feb 4, 202251
- FIRST TRUST PORTFOLIOS LPSC 13G/A, 1 filing Jan 10, 202252
SEC filer profile
How Tabula Rasa HealthCare, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARTabula Rasa HealthCare, Inc.1
- CIK0001651561
- Employer ID (EIN)46-57264371
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inDelaware1
- Fiscal year endsDecember 311
- Industry code (SIC)7389 Services-Business Services, NEC1
- Business address228 Strawbridge Drive, Suite 100, Moorestown, NJ 080571
- Phone866-648-27671
- Shares outstanding27,054,536 as of Jul 28, 202311
- Public float$49.5M as of Jun 30, 20224
- On EDGAR sinceAug 31, 20151
- Filings785 in all: 4 (450), 8-K (92), 3 (30), 4/A (27), 10-Q (21), SC 13G/A (19), DEFA14A (12), SC 13D/A (12)1
All 40 form types
EFFECT (11), SC 13G (11), CORRESP (9), POS AM (9), S-8 (9), 10-K (7), 8-K/A (7), DEF 14A (7), UPLOAD (7), D (5), DRSLTR (4), S-1/A (4), SC 13D (4), 3/A (3), 5 (3), DRS/A (3), 424B5 (2), 8-A12B (2), CT ORDER (2), 10-K/A (1), 15-12G (1), 25-NSE (1), 424B3 (1), 424B4 (1), ARS (1), CERTNAS (1), DEFM14A (1), DRS (1), PRE 14A (1), PREM14A (1), S-1 (1), S-3 (1)
- Latest filingsAnnual report (10-K) Mar 10, 2023
Quarterly report (10-Q) Aug 8, 2023
Proxy statement (DEF 14A) Apr 28, 2023
Latest 8-K (8-K) Nov 6, 2023
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGAROrsula Knowlton V., President
- 15
- 16
- 17
- 18SEC EDGARDerek C. Schrier, Board member
- 19SEC EDGARRonald Paul Mitchell, Board member
- 20SEC EDGARPamela Schweitzer, Board member
- 21SEC EDGARJan Berger, Board member
- 22SEC EDGARMichael J. Purcell, Board member
- 23SEC EDGARKathrine O'Brien, Board member
- 24SEC EDGARDennis Helling, Board member
- 25SEC EDGARSamira Beckwith, Board member
- 26SEC EDGARBruce Luehrs, Board member
- 27SEC EDGARDaniel C. Lubin, Board member
- 28SEC EDGARGlen R. Bressner, Board member
- 29SEC EDGARGordon Tunstall, Board member
- 30SEC EDGARRichard W. Rew Ii., General counsel
- 31
- 32SEC EDGARCompleted an acquisition or sale
- 33SEC EDGARShareholder vote; Other events
- 34SEC EDGAROther events
- 35
- 36SEC EDGARResults of operations
- 37SEC EDGARExecutive or director change
- 38SEC EDGARShareholder vote
- 39SEC EDGARRegulation FD disclosure
- 40SEC EDGARResults of operations
- 41
- 42SEC EDGARResults of operations
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52